Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting (CINV): A randomized phase III trial

被引：6
|
作者：
Navari, R. M.
Gray, S. E.
Kerr, A. C.
机构：
[1] Indiana Univ Sch Med, South Bend, IN USA
[2] Univ Notre Dame, South Bend, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.9020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9020
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Olanzapine versus Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting: A Randomized Phase III Trial
    Navari, R.
    Gray, S.
    Kerr, A.
    [J]. PSYCHO-ONCOLOGY, 2012, 21 : 111 - 112
  • [2] A phase II trial of olanzapine for the prevention of chemotherapy induced nausea and vomiting (CINV).
    Navari, RM
    Einhorn, LH
    Loehrer, PJ
    Passik, SD
    Vinson, J
    Mayer, ML
    Pletcher, W
    McClean, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 740S - 740S
  • [3] Combination of olanzapine and aprepitant in the prevention of chemotherapy-induced nausea and vomiting (CINV) in breast cancer patients.
    Shanthilal, Mukesh
    Sathya, M.
    Akshay, J. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Olanzapine versus aprepitant in the prevention of chemotherapy induced nausea and vomiting (CINV) in breast cancer patients.
    Mukesh, S.
    Sathya, M.
    Akshay, J. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] A phase II trial of olanzapine and palonosetron for the prevention of chemotherapy induced nausea and vomiting (CINV).
    Navari, R. M.
    Einhorn, L. H.
    Loehrer, P. J.
    Passik, S. D.
    Vinson, J.
    McClean, J.
    Chowhan, N.
    Hanna, N.
    Calley, C.
    Yu, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 495S - 495S
  • [6] Phase III study of NEPA, a fixed combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV).
    Zhang, Li
    Lu, Shun
    Feng, Ji Feng
    Dechaphunkul, Arunee
    Chessari, Salvatore
    Lanzarotti, Corinna
    Jordan, Karin
    Aapro, Matti S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Aprepitant for preventing chemotherapy-induced nausea and vomiting (CINV) in children
    Kang, Hyoung Jin
    Loftus, Susan
    Taylor, Arlene
    DiCristina, Cara
    Zwaan, Christian M.
    Green, Stuart
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Effect of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Women A Randomized Clinical Trial
    Wang, De-Shen
    Hu, Ming-Tao
    Wang, Zhi-Qiang
    Ren, Chao
    Qiu, Miao-Zhen
    Luo, Hui-Yan
    Jin, Ying
    Fong, William Pat
    Wang, Shu-bin
    Peng, Jie-wen
    Zou, Qing-feng
    Tan, Qiong
    Wang, Feng-Hua
    Li, Yu-Hong
    [J]. JAMA NETWORK OPEN, 2021, 4 (04)
  • [9] Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting
    Navari, Rudolph M.
    Qin, Rui
    Ruddy, Kathryn J.
    Liu, Heshan
    Powell, Steven F.
    Bajaj, Madhuri
    Dietrich, Leah
    Biggs, David
    Lafky, Jacqueline M.
    Loprinzi, Charles L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (02): : 134 - 142
  • [10] Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Adolescents
    Shiu, Jennifer R.
    Romanick, Marcel
    Stobart, Kent
    [J]. PEDIATRIC BLOOD & CANCER, 2009, 53 (07) : 1357 - 1357
12345